Related Experiment Videos
Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis
1Department of Medicine, Karolinska Hospital, Stockholm, Sweden.
Neurology
|June 1, 1995
Summary
Cytokine balance influences multiple sclerosis (MS) progression. Understanding T-helper 1 (TH1) and T-helper 2 (TH2) cytokine roles, like interleukin-10, is key for developing effective MS therapies.
Area of Science:
- Immunology
- Neuroscience
Background:
- Cytokine regulation critically impacts multiple sclerosis (MS) and experimental autoimmune encephalomyelitis outcomes.
- The autocrine/paracrine nature of cytokines complicates direct study, necessitating analysis of cellular production.
- Messenger RNA detection and cellular secretion assays are vital for understanding cytokine roles.
Purpose of the Study:
- To elucidate the influence of specific cytokine profiles on autoimmune neuroinflammatory diseases.
- To differentiate between disease-promoting and disease-limiting cytokine functions in MS models.
Main Methods:
- Analysis of cellular cytokine production via messenger RNA detection.
- Assessment of cellular cytokine secretion.
- Review of existing data on cytokine phenotypes (TH1, TH2) in disease models.
Main Results:
- T-helper 1 (TH1) associated cytokines (TNF-alpha, LT, IL-12, IFN-gamma) may exacerbate disease.
- T-helper 2 (TH2) associated cytokines (IL-10) show potential for disease limitation.
- Transforming growth factor beta identified as a potential disease downregulator.
Conclusions:
- The balance of TH1 and TH2 cytokines is a critical determinant of disease severity in MS.
- Targeting specific cytokine pathways, particularly IL-10 and TGF-beta, offers promising therapeutic strategies for MS.
- Further research into cytokine regulation is essential for advancing MS treatment.